Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

SHE/301301 stock hub

SHE/301301 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/301301is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

22.6B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/301301

In the news

Latest news · SHE/301301

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E24.7

P25 17.1P50 24.2P75 37.8

Trailing P/E38.8

P25 23.5P50 41.3P75 83.2

ROE7.2

P25 -0.9P50 4.1P75 8.8

ROIC7.2

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/301301 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

212

Groups with data

Currency

CNY

Showing 212 of 212 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	3,126
Employees Change	-58%
Employees Change Percent	-1.82
Enterprise value	CNY 23.2B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biotechnology
Last refreshed	2026-05-10
Market cap	CNY 22.6B
Price	CNY 10.14
Price currency	CNY
Rev Per Employee	1,411,970.08x
Sector	Healthcare
Sic	2834
Symbol	she/301301
Website	https://www.klcnsw.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.62%
EV Earnings	39.21x
EV/EBIT	30.31x
EV/EBITDA	17.06x
EV/FCF	45.38x
EV/Sales	5.25x
FCF yield	2.26%
Forward P/E	24.73x
P/B ratio	2.75x
P/E ratio	38.76x
P/S ratio	5.12x
PE Ratio3 Y	25.42x
PE Ratio5 Y	28.37x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	17.34%
EBITDA Margin	30.41%
FCF margin	11.58%
Gross margin	24.92%
Gross Profit	CNY 1.1B
Gross Profit Growth	-46.03%
Gross Profit Growth Q	-46.75%
Gross Profit Growth3 Y	3.83%
Net Income	CNY 591.5M
Net Income Growth	-55.72%
Net Income Growth Q	-61.58%
Net Income Growth3 Y	6.74%
Pretax Margin	16.48%
Profit Margin	13.4%
Profit Per Employee	CNY 189,225
ROA	4.53
Roa5y	6.06
ROCE	8.72
ROE	7.19
Roe5y	10.5
ROIC	7.16
Roic5y	10.17

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-9.51%
Cagr3y	5.62%
EPS Growth	-56.41
EPS Growth Q	-61.54
EPS Growth3 Y	2.55
FCF Growth	-68.82%
FCF Growth Q	55.72%
FCF Growth3 Y	-5.26%
OCF Growth	-62.42%
OCF Growth Q	56.69%
OCF Growth3 Y	-1.49%
Revenue Growth	-20.21x
Revenue Growth Q	-15.61x
Revenue Growth3 Y	2.54x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.42
Assets	CNY 10.4B
Cash	CNY 664.2M
Current Assets	CNY 4.2B
Current Liabilities	CNY 1.6B
Debt	CNY 1.2B
Debt EBITDA	CNY 0.9
Debt Equity	CNY 0.15
Debt FCF	CNY 2.39
Equity	CNY 8.2B
Interest Coverage	23.97
Liabilities	CNY 2.2B
Long Term Assets	CNY 6.2B
Long Term Liabilities	CNY 553.4M
Net Cash	CNY -554.9M
Net Cash By Market Cap	CNY -2.45
Net Debt EBITDA	CNY 0.41
Net Debt Equity	CNY 0.07
Net Debt FCF	CNY 1.09
Tangible Book Value	CNY 8B
Tangible Book Value Per Share	CNY 3.57
WACC	4.77

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.57
Inventory Turnover	2.66
Net Working Capital	CNY 2.7B
Quick ratio	1.64
Working Capital	CNY 2.6B
Working Capital Turnover	CNY 1.76

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.58%
Dividend Growth	-35.84%
Dividend Growth Years	3%
Dividend per share	CNY 0.17
Dividend Years	4
Dividend Yield	1.71%
Ex Div Date	2026-04-29
Last Dividend	CNY 0.17
Payout Frequency	Annual
Payout Ratio	105.09%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-9.5%
200-day SMA	11.14
3Y total return	17.82%
50-day SMA	10.68
50-day SMA vs 200-day SMA	50under200
All Time High	18.33
All Time High Change	-44.68%
All Time High Date	2024-05-08
All Time Low	6.94
All Time Low Change	46.11%
All Time Low Date	2024-02-05
ATR	0.29
Beta	0.12
Beta1y	0.36
Beta2y	0.67
High	10.14
High52	14.74
High52 Date	2025-05-16
High52ch	-31.21%
Low	9.96
Low52	9.6
Low52 Date	2026-04-29
Low52ch	5.63%
Ma50ch	-5.08%
Price vs 200-day SMA	-8.98%
RSI	46.16
RSI Monthly	45.58
RSI Weekly	41.92
Sharpe ratio	-0.34x
Sortino ratio	-0.39
Total Return	0.13%
Tr YTD	1.81
Tr1m	-1.31%
Tr1w	1.4%
Tr3m	-8.08%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 765.3M
Operating Income Growth	-53.86
Operating Income Growth Q	-57.16
Operating Income Growth3 Y	0.62
Operating margin	17.34

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	508,210,599%
Net Borrowing	-194,613,079
Shares Insiders	0.08%
Shares Institutions	5.28%
Shares Out	2,230,085,000
Shares Qo Q	-1.75%
Shares Yo Y	1.58%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 511.1M
Average Volume	12,633,048.95x
Bv Per Share	3.67
CAPEX	CNY -104M
Ch1m	-3.06
Ch1w	1.4
Ch1y	-12.96
Ch3m	-9.71
Ch3y	10.58
Ch6m	-9.79
Change	1.6%
Change From Open	1.71
Close	9.98
Days Gap	-0.1
Depreciation Amortization	576,894,075
Dollar Volume	106,083,564.6
Earnings Date	2026-08-18
EBIT	CNY 765.3M
EBITDA	CNY 1.3B
EPS	CNY 0.26
F Score	5
FCF	CNY 511.1M
FCF EV Yield	2.2x
FCF Per Share	CNY 0.23
Financing CF	-823,981,733
Fiscal Year End	December
Founded	2,010
Goodwill	1,365,974
Graham Number	4.65041
Graham Upside	-54.14
Income Tax	CNY 137.2M
Investing CF	-78,879,617
Is Primary Listing	1
Last Earnings Date	2026-03-31
Last Report Date	2026-03-31
Lynch Fair Value	CNY 1.76
Lynch Upside	-82.61
Ma150	10.8
Ma150ch	-6.12%
Ma20	10.16
Ma20ch	-0.19%
Net CF	-292,046,434
Next Earnings Date	2026-08-18
Open	9.97
P FCF Ratio	44.24
P OCF Ratio	36.76
Payment Date	2026-04-29
Position In Range	100
Ppne	5,668,399,510
Price Date	2026-05-08
Price EBITDA	CNY 16.85
Ptbv Ratio	2.84
Relative Volume	0.83x
Revenue	4,413,818,474x
Tax By Revenue	3.11x
Tax Rate	18.87%
Tr6m	-8.16%
Volume	10,461,890
Z Score	8.4

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/301301 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.7%

$0.17 annual per share

Payout ratio

+105.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

3 consecutive years of growth

Total shareholder yield

+0.1%

Next ex-dividend date: 2026-04-29

Performance

SHE/301301 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/301301?

Insider, institutional, and short-interest positioning.

Institutional ownership

+5.3%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+1.6%

Negative means the company is buying back shares.

Technical

SHE/301301 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.2

Neutral momentum band

Price vs 200-day MA

-9.0%

50/200-day relationship not available

Beta (5Y)

0.12

Less volatile than the market

Sharpe ratio

-0.34

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/301301

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/301301 stock rating?

she/301301 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/301301 analysis?

The full report lives at /stocks/she/301301/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/301301?

The latest report frames she/301301 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/301301 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.